Clinical trial
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
NCT00462813 · Barts and the London School of Medicine and Dentistry, Other · Completed
Key facts
| NCT number | NCT00462813 |
|---|---|
| Title | Diindolylmethane in Treating Patients With Abnormal Cervical Cells |
| Official title | An Investigation Into the Effects of Diidolylmethane (BioResponse DIM®) Supplementation in Women With Low-Grade Cervical Cytological Abnormalities [CRISP-1] |
| Lead sponsor | Barts and the London School of Medicine and Dentistry, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Precancerous Condition |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | oral microencapsulated diindolylmethane, polymerase chain reaction, cervical Papanicolaou test, cytology specimen collection procedure, colposcopic biopsy |
| Enrollment | 3,000 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Jan 1, 2010 |
| First posted | Apr 19, 2007 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: